Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 296 | $222,861,020 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
21 Jul 2022 16:48 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 19 Jul 2022 | Sale | 6,604 | 289.48 | 1,911,726 | D |
21 Jul 2022 16:48 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 19 Jul 2022 | Sale | 5,737 | 288.67 | 1,656,100 | D |
21 Jul 2022 16:48 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 19 Jul 2022 | Sale | 4,561 | 287.83 | 1,312,793 | D |
21 Jul 2022 16:48 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 19 Jul 2022 | Sale | 963 | 286.72 | 276,111 | D |
27 Jul 2022 16:17 | VRTX | VERTEX PHARMACEUTICALS INC | LEIDEN JEFFREY M | Executive Chairman | 25 Jul 2022 | Sale | 10,471 | 283.42 | 2,967,691 | D |
27 Jul 2022 16:17 | VRTX | VERTEX PHARMACEUTICALS INC | LEIDEN JEFFREY M | Executive Chairman | 25 Jul 2022 | Sale | 40,666 | 282.43 | 11,485,298 | D |
27 Jul 2022 16:17 | VRTX | VERTEX PHARMACEUTICALS INC | LEIDEN JEFFREY M | Executive Chairman | 25 Jul 2022 | Sale | 34,090 | 281.27 | 9,588,494 | D |
27 Jul 2022 16:17 | VRTX | VERTEX PHARMACEUTICALS INC | LEIDEN JEFFREY M | Executive Chairman | 25 Jul 2022 | Sale | 32,983 | 280.37 | 9,247,444 | D |
27 Jul 2022 16:17 | VRTX | VERTEX PHARMACEUTICALS INC | LEIDEN JEFFREY M | Executive Chairman | 25 Jul 2022 | Sale | 13,869 | 279.44 | 3,875,553 | D |
02 Aug 2022 16:16 | VRTX | VERTEX PHARMACEUTICALS INC | BHATIA SANGEETA N. | Director | 29 Jul 2022 | Sale | 5 | 282.34 | 1,412 | D |
02 Aug 2022 16:16 | VRTX | VERTEX PHARMACEUTICALS INC | BHATIA SANGEETA N. | Director | 29 Jul 2022 | Sale | 58 | 281.03 | 16,300 | D |
02 Aug 2022 16:16 | VRTX | VERTEX PHARMACEUTICALS INC | BHATIA SANGEETA N. | Director | 29 Jul 2022 | Sale | 99 | 280.22 | 27,742 | D |
02 Aug 2022 16:16 | VRTX | VERTEX PHARMACEUTICALS INC | BHATIA SANGEETA N. | Director | 29 Jul 2022 | Sale | 160 | 279.28 | 44,685 | D |
02 Aug 2022 16:16 | VRTX | VERTEX PHARMACEUTICALS INC | BHATIA SANGEETA N. | Director | 29 Jul 2022 | Sale | 200 | 277.95 | 55,590 | D |
02 Aug 2022 16:16 | VRTX | VERTEX PHARMACEUTICALS INC | BHATIA SANGEETA N. | Director | 29 Jul 2022 | Sale | 99 | 276.65 | 27,388 | D |
10 Aug 2022 16:06 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 08 Aug 2022 | Sale | 146 | 295.14 | 43,090 | D |
10 Aug 2022 16:06 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 08 Aug 2022 | Sale | 302 | 293.99 | 88,785 | D |
10 Aug 2022 16:06 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 08 Aug 2022 | Sale | 210 | 293.02 | 61,534 | D |
10 Aug 2022 16:06 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 08 Aug 2022 | Sale | 424 | 291.53 | 123,609 | D |
10 Aug 2022 16:06 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 08 Aug 2022 | Sale | 222 | 290.32 | 64,451 | D |
10 Aug 2022 16:06 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 09 Aug 2022 | Sale | 900 | 301.42 | 271,278 | D |
10 Aug 2022 16:06 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 09 Aug 2022 | Sale | 4,790 | 300.53 | 1,439,539 | D |
10 Aug 2022 16:06 | VRTX | VERTEX PHARMACEUTICALS INC | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 09 Aug 2022 | Sale | 74 | 301.67 | 22,324 | D |
10 Aug 2022 16:06 | VRTX | VERTEX PHARMACEUTICALS INC | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 09 Aug 2022 | Sale | 72 | 300.64 | 21,646 | D |
10 Aug 2022 16:06 | VRTX | VERTEX PHARMACEUTICALS INC | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 09 Aug 2022 | Sale | 283 | 299.79 | 84,841 | D |
10 Aug 2022 16:06 | VRTX | VERTEX PHARMACEUTICALS INC | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 09 Aug 2022 | Sale | 679 | 298.77 | 202,865 | D |
10 Aug 2022 16:06 | VRTX | VERTEX PHARMACEUTICALS INC | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 09 Aug 2022 | Sale | 292 | 297.54 | 86,882 | D |
10 Aug 2022 16:06 | VRTX | VERTEX PHARMACEUTICALS INC | LIU JOY | SVP, General Counsel | 09 Aug 2022 | Sale | 946 | 300 | 283,800 | D |
10 Aug 2022 16:07 | VRTX | VERTEX PHARMACEUTICALS INC | BHATIA SANGEETA N. | Director | 08 Aug 2022 | Sale | 47 | 295.53 | 13,890 | D |
10 Aug 2022 16:07 | VRTX | VERTEX PHARMACEUTICALS INC | BHATIA SANGEETA N. | Director | 08 Aug 2022 | Sale | 161 | 294.24 | 47,373 | D |
10 Aug 2022 16:07 | VRTX | VERTEX PHARMACEUTICALS INC | BHATIA SANGEETA N. | Director | 08 Aug 2022 | Sale | 204 | 293.15 | 59,803 | D |
10 Aug 2022 16:07 | VRTX | VERTEX PHARMACEUTICALS INC | BHATIA SANGEETA N. | Director | 08 Aug 2022 | Sale | 164 | 291.76 | 47,849 | D |
10 Aug 2022 16:07 | VRTX | VERTEX PHARMACEUTICALS INC | BHATIA SANGEETA N. | Director | 08 Aug 2022 | Sale | 45 | 290.18 | 13,058 | D |
12 Aug 2022 16:05 | VRTX | VERTEX PHARMACEUTICALS INC | LIU JOY | SVP, General Counsel | 10 Aug 2022 | Sale | 36 | 300.32 | 10,812 | D |
12 Aug 2022 16:05 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 10 Aug 2022 | Sale | 9 | 302.01 | 2,718 | D |
12 Aug 2022 16:05 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 10 Aug 2022 | Sale | 171 | 300.32 | 51,355 | D |
17 Aug 2022 17:36 | VRTX | VERTEX PHARMACEUTICALS INC | LIU JOY | SVP, General Counsel | 15 Aug 2022 | Sale | 300 | 305.57 | 91,671 | D |
17 Aug 2022 17:36 | VRTX | VERTEX PHARMACEUTICALS INC | LIU JOY | SVP, General Counsel | 15 Aug 2022 | Sale | 1,743 | 305.01 | 531,632 | D |
17 Aug 2022 17:36 | VRTX | VERTEX PHARMACEUTICALS INC | LIU JOY | SVP, General Counsel | 15 Aug 2022 | Sale | 700 | 303.99 | 212,793 | D |
17 Aug 2022 17:36 | VRTX | VERTEX PHARMACEUTICALS INC | LIU JOY | SVP, General Counsel | 15 Aug 2022 | Sale | 100 | 302.35 | 30,235 | D |
17 Aug 2022 17:36 | VRTX | VERTEX PHARMACEUTICALS INC | LIU JOY | SVP, General Counsel | 15 Aug 2022 | Sale | 698 | 301.63 | 210,538 | D |
17 Aug 2022 17:36 | VRTX | VERTEX PHARMACEUTICALS INC | LIU JOY | SVP, General Counsel | 15 Aug 2022 | Sale | 206 | 300.26 | 61,854 | D |
17 Aug 2022 17:39 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 15 Aug 2022 | Sale | 6,948 | 305.38 | 2,121,780 | D |
17 Aug 2022 17:39 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 15 Aug 2022 | Sale | 6,990 | 304.67 | 2,129,643 | D |
17 Aug 2022 17:39 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 15 Aug 2022 | Sale | 2,339 | 303.78 | 710,541 | D |
17 Aug 2022 17:39 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 15 Aug 2022 | Sale | 400 | 302.55 | 121,020 | D |
17 Aug 2022 17:39 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 15 Aug 2022 | Sale | 4,242 | 301.61 | 1,279,430 | D |
17 Aug 2022 17:39 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 15 Aug 2022 | Sale | 1,254 | 300.3 | 376,576 | D |
17 Aug 2022 17:40 | VRTX | VERTEX PHARMACEUTICALS INC | KEWALRAMANI RESHMA | CEO & President | 15 Aug 2022 | Sale | 11,689 | 305.06 | 3,565,846 | D |
20 Oct 2022 16:11 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 18 Oct 2022 | Sale | 288 | 301.84 | 86,930 | D |
20 Oct 2022 16:11 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 18 Oct 2022 | Sale | 1,503 | 300.02 | 450,930 | D |
26 Oct 2022 16:05 | VRTX | VERTEX PHARMACEUTICALS INC | BHATIA SANGEETA N. | Director | 24 Oct 2022 | Sale | 621 | 310 | 192,510 | D |
03 Nov 2022 16:05 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 02 Nov 2022 | Sale | 22 | 317.77 | 6,991 | D |
03 Nov 2022 16:05 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 02 Nov 2022 | Sale | 10 | 315.68 | 3,157 | D |
03 Nov 2022 16:05 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 02 Nov 2022 | Sale | 12 | 314.43 | 3,773 | D |
03 Nov 2022 16:05 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 02 Nov 2022 | Sale | 81 | 313.37 | 25,383 | D |
03 Nov 2022 16:05 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 02 Nov 2022 | Sale | 100 | 312.4 | 31,240 | D |
03 Nov 2022 16:05 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 02 Nov 2022 | Sale | 39 | 311.17 | 12,136 | D |
03 Nov 2022 16:05 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 02 Nov 2022 | Sale | 56 | 310.1 | 17,366 | D |
09 Nov 2022 16:40 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 07 Nov 2022 | Sale | 83 | 306.57 | 25,445 | D |
09 Nov 2022 16:40 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 07 Nov 2022 | Sale | 140 | 305.39 | 42,755 | D |
09 Nov 2022 16:40 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 07 Nov 2022 | Sale | 280 | 304.58 | 85,282 | D |
09 Nov 2022 16:40 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 07 Nov 2022 | Sale | 261 | 303.21 | 79,138 | D |
09 Nov 2022 16:40 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 07 Nov 2022 | Sale | 189 | 301.99 | 57,076 | D |
09 Nov 2022 16:40 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 07 Nov 2022 | Sale | 210 | 300.96 | 63,202 | D |
09 Nov 2022 16:40 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 07 Nov 2022 | Sale | 140 | 299.72 | 41,961 | D |
17 Nov 2022 16:08 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 15 Nov 2022 | Sale | 34 | 308.61 | 10,493 | D |
19 Jan 2023 16:07 | VRTX | VERTEX PHARMACEUTICALS INC | LEE YUCHUN | Director | 18 Jan 2023 | Sale | 442 | 312.17 | 137,979 | D |
19 Jan 2023 16:07 | VRTX | VERTEX PHARMACEUTICALS INC | LEE YUCHUN | Director | 17 Jan 2023 | Sale | 4,000 | 312.03 | 1,248,120 | D |
25 Jan 2023 16:08 | VRTX | VERTEX PHARMACEUTICALS INC | LEE YUCHUN | Director | 24 Jan 2023 | Sale | 1,489 | 313.36 | 466,593 | D |
25 Jan 2023 16:08 | VRTX | VERTEX PHARMACEUTICALS INC | LEE YUCHUN | Director | 24 Jan 2023 | Sale | 2,511 | 312.29 | 784,160 | D |
25 Jan 2023 16:08 | VRTX | VERTEX PHARMACEUTICALS INC | LEE YUCHUN | Director | 23 Jan 2023 | Sale | 2,129 | 312.02 | 664,291 | D |
27 Jan 2023 16:13 | VRTX | VERTEX PHARMACEUTICALS INC | KEWALRAMANI RESHMA | CEO & President | 25 Jan 2023 | Sale | 10,000 | 315.05 | 3,150,500 | D |
27 Jan 2023 16:18 | VRTX | VERTEX PHARMACEUTICALS INC | LEE YUCHUN | Director | 26 Jan 2023 | Sale | 680 | 320.94 | 218,239 | D |
27 Jan 2023 16:18 | VRTX | VERTEX PHARMACEUTICALS INC | LEE YUCHUN | Director | 26 Jan 2023 | Sale | 400 | 320.25 | 128,100 | D |
27 Jan 2023 16:18 | VRTX | VERTEX PHARMACEUTICALS INC | LEE YUCHUN | Director | 26 Jan 2023 | Sale | 478 | 319.25 | 152,602 | D |
27 Jan 2023 16:18 | VRTX | VERTEX PHARMACEUTICALS INC | LEE YUCHUN | Director | 26 Jan 2023 | Sale | 1,000 | 317.95 | 317,950 | D |
27 Jan 2023 16:18 | VRTX | VERTEX PHARMACEUTICALS INC | LEE YUCHUN | Director | 26 Jan 2023 | Sale | 1,140 | 316.82 | 361,175 | D |
27 Jan 2023 16:18 | VRTX | VERTEX PHARMACEUTICALS INC | LEE YUCHUN | Director | 26 Jan 2023 | Sale | 302 | 315.42 | 95,257 | D |
27 Jan 2023 16:18 | VRTX | VERTEX PHARMACEUTICALS INC | LEE YUCHUN | Director | 25 Jan 2023 | Sale | 579 | 314.95 | 182,356 | D |
27 Jan 2023 16:18 | VRTX | VERTEX PHARMACEUTICALS INC | LEE YUCHUN | Director | 25 Jan 2023 | Sale | 2,621 | 314.1 | 823,256 | D |
27 Jan 2023 16:18 | VRTX | VERTEX PHARMACEUTICALS INC | LEE YUCHUN | Director | 25 Jan 2023 | Sale | 800 | 312.8 | 250,240 | D |
31 Jan 2023 16:42 | VRTX | VERTEX PHARMACEUTICALS INC | LEE YUCHUN | Director | 27 Jan 2023 | Sale | 80 | 323.33 | 25,866 | D |
31 Jan 2023 16:42 | VRTX | VERTEX PHARMACEUTICALS INC | LEE YUCHUN | Director | 27 Jan 2023 | Sale | 970 | 322.2 | 312,534 | D |
31 Jan 2023 16:42 | VRTX | VERTEX PHARMACEUTICALS INC | LEE YUCHUN | Director | 27 Jan 2023 | Sale | 379 | 321.31 | 121,776 | D |
31 Jan 2023 16:45 | VRTX | VERTEX PHARMACEUTICALS INC | CARNEY LLOYD | Director | 30 Jan 2023 | Sale | 324 | 321.84 | 104,276 | D |
31 Jan 2023 16:45 | VRTX | VERTEX PHARMACEUTICALS INC | CARNEY LLOYD | Director | 30 Jan 2023 | Sale | 1,000 | 320.7 | 320,700 | D |
31 Jan 2023 16:45 | VRTX | VERTEX PHARMACEUTICALS INC | CARNEY LLOYD | Director | 30 Jan 2023 | Sale | 1,376 | 320.08 | 440,430 | D |
02 Feb 2023 16:14 | VRTX | VERTEX PHARMACEUTICALS INC | SACHS BRUCE I | Director | 31 Jan 2023 | Sale | 1,200 | 325.01 | 390,012 | D |
02 Feb 2023 16:18 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 31 Jan 2023 | Sale | 106 | 325 | 34,450 | D |
08 Feb 2023 16:53 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 06 Feb 2023 | Sale | 153 | 309.06 | 47,286 | D |
08 Feb 2023 16:53 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 06 Feb 2023 | Sale | 620 | 306.7 | 190,154 | D |
08 Feb 2023 16:53 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 06 Feb 2023 | Sale | 349 | 305.08 | 106,473 | D |
08 Feb 2023 16:53 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 06 Feb 2023 | Sale | 100 | 303.64 | 30,364 | D |
08 Feb 2023 16:53 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 06 Feb 2023 | Sale | 70 | 302 | 21,140 | D |
08 Feb 2023 16:53 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 06 Feb 2023 | Sale | 12 | 300.39 | 3,605 | D |
14 Feb 2023 16:49 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 13 Feb 2023 | Sale | 500 | 300.23 | 150,115 | D |
14 Feb 2023 16:49 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 13 Feb 2023 | Sale | 1,893 | 299.36 | 566,688 | D |
14 Feb 2023 16:49 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 13 Feb 2023 | Sale | 2,160 | 298.47 | 644,695 | D |
14 Feb 2023 16:49 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 13 Feb 2023 | Sale | 245 | 296.44 | 72,628 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)